Testosterone therapy in the aging male (Q58249332)

https://api.crossref.org/works/10.1080%2F13685530701485998

An examination of research design effects on the association of testosterone and male aging: Results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Investigation, treatment and monitoring of late-onset hypogonadism in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Determinants of bone density in healthy older men with low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Body composition, sex steroids, IGF-1, and bone mineral status in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Serum testosterone and its relation to bone mineral density and body composition in normal males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Association of Hypogonadism and Estradiol Levels with Bone Mineral Density in Elderly Men from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Predictors of skeletal muscle mass in elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Relationships of sex hormone levels to dependence in activities of daily living in the frail elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

The relationship between pituitary-gonadal function and sexual behavior in healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

The evolving role of testosterone in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

The blood in systemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Age-associated testosterone decline in men: clinical issues for psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Serum testosterone measurement in men: evaluation of modern immunoassay technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone treatment comes of age: new options for hypogonadal men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Androgens and the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Psychoendocrine sequelae of chronic testosterone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Obstructive sleep apnea syndrome induced by testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Reversible reproductive dysfunction in men with obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

THE MALE CLIMACTERIC, ITS SYMPTOMATOLOGY, DIAGNOSIS AND TREATMENT

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone and regional fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Changes in cerebral glucose metabolism and visuospatial capability in hypogonadal males under testosterone substitution therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone and cognition in elderly men: a single testosterone injection blocks the practice effect in verbal fluency, but has no effect on spatial or verbal memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone influences spatial cognition in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone treatment enhances regional brain perfusion in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone release rate and duration of action of testosterone pellet implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

An analysis of testosterone implants for androgen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Important effect of food on the bioavailability of oral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Androgen replacement therapy: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Psychosexual effects of three doses of testosterone cycling in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998

Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13685530701485998